Chiron Vision files FDA application to market intraocular implant for CMV retinitis. Food and Drug Administration.
D017326:Clinical Trials, Phase III as Topic; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D017277:Drug Approval; D004343:Drug Implants; D015774:Ganciclovir / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D014481:United States; D014486:United States Food and Drug Administration
D003692:Delayed-Action Preparations; D004343:Drug Implants; D015774:Ganciclovir